Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Carolyn A. Keever-Taylor"'
Autor:
Jordan Milner, Allyson Flower, Stephanie Schulman, Carolyn A Keever-Taylor, Sandra Fabricatore, Erin Morris, Harshini Mahanti, Qiuhu Shi, Rosemarie Shaw, Rona Singer Weinberg, Brenda Grossman, Julie-An Talano, Shalini Shenoy, Theodore B. Moore, Janet Ayello, Carmella van de Ven, Mitch S. Cairo
Publikováno v:
Transplantation and Cellular Therapy. 28:S248-S250
Autor:
Carolyn A. Keever-Taylor, Nirav N. Shah, Boro Dropulic, Rimas J. Orentas, Sharon Yim, Winfried Krueger, Michael Kadan, Mehdi Hamadani, Ashley M. Cunningham, Andrew Worden, Timothy S. Fenske, Aniko Szabo, Fenlu Zhu, Parameswaran Hari, Dina Schneider, Bryon D. Johnson
Publikováno v:
Nature Medicine. 26:1569-1575
Chimeric antigen receptor (CAR) T cells targeting CD19 are a breakthrough treatment for relapsed, refractory B cell malignancies1–5. Despite impressive outcomes, relapse with CD19− disease remains a challenge. We address this limitation through a
Autor:
Carolyn A. Keever-Taylor, Dimitri S. Monos, Yongping Wang, Nancy Bunin, David M. Barrett, Alix E. Seif, Timothy S. Olson, Jason L. Freedman, David A. Margolis, James T. Casper, Yimei Li, Richard Aplenc, Stephanie C. Heidemann, Julie-An Talano, David T. Teachey, Stephan A. Grupp
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:493-501
Most children who may benefit from stem cell transplantation lack a matched related donor. Alternative donor transplantations with an unrelated donor (URD) or a partially matched related donor (PMRD) carry an increased risk of graft-versus-host-disea
Autor:
Carolyn A. Keever-Taylor
Publikováno v:
Cell Therapy ISBN: 9783030755355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aee113da3a4a0832835d2073e5b26c3a
https://doi.org/10.1007/978-3-030-75537-9_25
https://doi.org/10.1007/978-3-030-75537-9_25
Autor:
Nirav N, Shah, Bryon D, Johnson, Dina, Schneider, Fenlu, Zhu, Aniko, Szabo, Carolyn A, Keever-Taylor, Winfried, Krueger, Andrew A, Worden, Michael J, Kadan, Sharon, Yim, Ashley, Cunningham, Mehdi, Hamadani, Timothy S, Fenske, Boro, Dropulić, Rimas, Orentas, Parameswaran, Hari
Publikováno v:
Nature medicine. 26(10)
Chimeric antigen receptor (CAR) T cells targeting CD19 are a breakthrough treatment for relapsed, refractory B cell malignancies
Autor:
Bryon D. Johnson, Nirav N. Shah, Mary M. Horowitz, Wael Saber, Renee Dunn, Mary Eapen, Mehdi Hamadani, Carolyn A. Keever-Taylor, Sharon Yim, William R. Drobyski, Bronwen E. Shaw, Marcelo C. Pasquini, Timothy S. Fenske, Aniko Szabo, Kyle Hebert, Anita D'Souza, J. Douglas Rizzo, Fenlu Zhu, Parameswaran Hari
Publikováno v:
Haematologica. 103:717-727
We conducted a phase 2 study in which patients undergoing allogeneic hematopoietic stem cell transplantation received tocilizumab in addition to standard immune suppression with tacrolimus and methotrexate for graft-versus-host disease prophylaxis. T
Autor:
Allyson Flower, O. Militano, Rona Singer Weinberg, James W. Verbsky, Jordan Milner, Carolyn A. Keever-Taylor, Deborah M. Friedman, Erin Morris, Liana Klejmont, Theodore B Moore, Susan K. Parsons, Mitchell S. Cairo, Qiuhu Shi, Janet Ayello, Brenda J. Grossman, Harshini Mahanti, Suzanne Braniecki, Robert C. McKinstry, E. Vichinsky, Carmella van de Ven, Shalini Shenoy, Julie-An Talano, Yaya Chu, Marise D'Souza, Allen J. Dozor, LA Baxter-Lowe, Sandra Fabricatore, Chitti R Moorthy, Mark C. Walters
Publikováno v:
Transplantation and Cellular Therapy. 27:S316-S317
Autor:
Rona Singer Weinberg, Qiuhu Shi, Theodore B. Moore, Carolyn A. Keever-Taylor, Julie-An Talano, Harshini Mahanti, Shalini Shenoy, Brenda J. Grossman, Carmella van de Ven, Bryon D. Johnson, Erin Morris, Yaya Chu, Lee Ann Baxter-Lowe, Sandra Fabricatore, Mitchell S. Cairo, Janet Ayello
Publikováno v:
Blood. 136:20-21
Background: CD3/CD19 cell depletion (Barfiled RC, et al, Cytotherapy, 2004), αβ T-cell/CD19 cell depletion (Locatelli F, et al, Blood, 2017), CD34+ positive selection (Aversa F, et al, NEJM, 1998) are designed to deplete T cells and reduce AGVHD fo
Autor:
Keith M. Sullivan, Linda M. Griffith, Kaitlyn C. Steinmiller, Shelly Heimfeld, Tomeka C. Granderson, Christine W. Czarniecki, Julia S. Goldstein, Richard A. Nash, Carolyn A. Keever-Taylor
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:1463-1472
To ensure comparable grafts for autologous hematopoietic cell transplantation (HCT) in the National Institute of Allergy and Infectious Diseases–sponsored Investigational New Drug protocols for multiple sclerosis (HALT-MS) and systemic sclerosis (S
Autor:
Melodee Nugent, Subramaniam Malarkannan, Carolyn A. Keever-Taylor, David A. Margolis, Pippa Simpson, Monica S. Thakar, Nicole Liberio, Haley Robinson
Publikováno v:
Pediatr Blood Cancer
Background Donor lymphocyte infusion (DLI) is often used to treat leukemic relapse after hematopoietic cell transplantation (HCT). However, the relationship between outcomes and distinct DLI cellular composition has not been previously reported. Addi